Madrigal Pharmaceuticals Surges After Positive Test Results
Madrigal Pharmaceuticals (MDGL:NYQ) stock is up 250% intraday on successful results from its Liver Disease trials. The company has been working on a late-stage clinical trial to treat liver disease, which prompted the surge in price. The company is off...